Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Genetic Landscape of BPDCN Arising in CML Remission

Masataka Takeshita, Nobuyuki Kodama, Tomoko Hishima, Koji Okazaki, Akira Tanimura, Risen Hirai, Naomi Abe, Daisuke Kudo, Seishi Ogawa, Yasuhito Nannya, Akiyoshi Miwa

Blood (2022) 140 (Supplement 1): 11801–11803.

https://doi.org/10.1182/blood-2022-168948

Published: 2022

Journal Articles

Impact of Combining Frailty Assessment Systems to Select Elderly Myeloma Patients Eligible for Autologous Peripheral Blood Stem Cell Transplantation

Akira Tanimura, Koji Okazaki, MD, Yuko Okuda, MD, Risen Hirai, MD, Daisuke Kudo, MD, Masataka Takeshita, MD PhD, Akiyoshi Miwa, MD, PhD

Blood (2019) 134 (Supplement_1): 5706.

https://doi.org/10.1182/blood-2019-122084

Published: 2019

Journal Articles

Application of Hematopoietic Progenitor Cell Count: To Optimize Peripheral Blood Stem Cell Harvest

Masataka Takeshita, MD PhD, Risen Hirai, MD, Akira Tanimura, MD, Miki Nakamura, MD PhD, Shotaro Hagiwara, MD PhD, Akiyoshi Miwa, MD PhD

Blood (2014) 124 (21): 5837.

https://doi.org/10.1182/blood.V124.21.5837.5837

Published: 2014

Journal Articles

‘in Vivo Labelling Index System' in Myelomology Using an Innovative Thio-Thymidine PET/CT Combined with Amino-Acid PET/CT with Higher Visualizing Efficiency Than Conventional FDG PET/CT. - SUVmax by Thio-Thymidine PET/CT which Can Detect DNA-Synthesizing Myeloma Cell Nests in Vivo, Strongly Correlated with FISH Abnormalities in 74 Plasma Cell Dyscrasia Patients

Akiyoshi Miwa, MD, PhD, Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Kazuo Kubota, MD, PhD, Momoko Okazaki, MD

Blood (2013) 122 (21): 1858.

https://doi.org/10.1182/blood.V122.21.1858.1858

Published: 2013

Journal Articles

The Spectrum Of Pathological Findings Of Kidney Injury In The Cases Of Multiple Myeloma: A Clinico-Pathological Study Of 93 Consecutive Autopsy Cases

Sohtaro Mine, MD, Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Akira Tanimura, MD, Miki Nakamura, MD, PhD, Masataka Takeshita, MD, PhD, Akiyoshi Miwa, MD, PhD, Toru Igari, MD PhD

Blood (2013) 122 (21): 5321.

https://doi.org/10.1182/blood.V122.21.5321.5321

Published: 2013

Journal Articles

Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents

Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Miki Nakamura, MD, PhD, Akira Tanimura, MD, Masataka Takeshita, MD, PhD, Akiyoshi Miwa, MD, PhD

Blood (2013) 122 (21): 2171.

https://doi.org/10.1182/blood.V122.21.2171.2171

Published: 2013

Journal Articles

What Is the Appropriate Dose Attenuation System of RCHOP for Elderly DLBCL Patients? - A Single Institutional Analysis in 115 Cosecutive Patients From Japan -

Akira Tanimura, MD, Risen Hirai, MD, Atsushi Sato, MD, Miki Nakamura, MD, PhD, Masataka Takeshita, MD, PhD, Shotaro Hagiwara, MD, PhD, Akiyoshi Miwa, MD

Blood (2012) 120 (21): 3639.

https://doi.org/10.1182/blood.V120.21.3639.3639

Published: 2012

Journal Articles

High-Dose Cyclophosphamide + G-CSF Mobilization Regimen Have Higher Anti-Myeloma Effects Than G-CSF Alone Regimen – Single Institutional Study in 147 Myeloma Patients From Japan

Akira Tanimura, MD, Masataka Takeshita, MD, PhD, Atsushi Sato, MD, Junichiro Takano, MD, Hideaki Kitahara, MD, Ayato Tsukamoto, MD, Yuko Kimura, MD, Risen Hirai, MD, Miki Nakamura, MD, PhD, Shotaro Hagiwara, MD, PhD, Mineo Kurokawa, MD, PhD, Akiyoshi Miwa, MD

Blood (2011) 118 (21): 2007.

https://doi.org/10.1182/blood.V118.21.2007.2007

Published: 2011

Journal Articles

Direct Myeloma Cell Invasion as One of the Major Causes of Renal Impairment In Myeloma A Pathological Analysis of Renal Findings In 41 Autopsied Cases

Amane Tagashira, MD., Junichiro Takano, MD., Shotaro Hagiwara, MD., PhD., Makoto Mochizuki, MD., PhD., Hisako Endo, MD., PhD., Risen Hirai, MD., Akira Tanimura, MD., Masataka Takeshita, MD., PhD., Hirokazu Murakami, MD, PhD, Akiyoshi Miwa, MD.

Blood (2010) 116 (21): 5001.

https://doi.org/10.1182/blood.V116.21.5001.5001

Published: 2010

Journal Articles

Multi-Organ Involvement of Multiple Myeloma Cells In the Cases of Recent 10 Years: A Clinicopathologic Study of 81 Consecutively Autopsied Cases

Shotaro Hagiwara, MD., PhD., Makoto Mochizuki, MD., PhD., Hisako Endo, MD., PhD., Risen Hirai, MD., Akira Tanimura, MD., Masataka Takeshita, MD., PhD., Hirokazu Murakami, MD, PhD, Akiyoshi Miwa, MD.

Blood (2010) 116 (21): 5004.

https://doi.org/10.1182/blood.V116.21.5004.5004

Published: 2010

NARROW

Genetic Landscape of BPDCN Arising in CML Remission

Impact of Combining Frailty Assessment Systems to Select Elderly Myeloma Patients Eligible for Autologous Peripheral Blood Stem Cell Transplantation

Application of Hematopoietic Progenitor Cell Count: To Optimize Peripheral Blood Stem Cell Harvest

The Spectrum Of Pathological Findings Of Kidney Injury In The Cases Of Multiple Myeloma: A Clinico-Pathological Study Of 93 Consecutive Autopsy Cases

Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents

What Is the Appropriate Dose Attenuation System of RCHOP for Elderly DLBCL Patients? - A Single Institutional Analysis in 115 Cosecutive Patients From Japan -

High-Dose Cyclophosphamide + G-CSF Mobilization Regimen Have Higher Anti-Myeloma Effects Than G-CSF Alone Regimen – Single Institutional Study in 147 Myeloma Patients From Japan

Direct Myeloma Cell Invasion as One of the Major Causes of Renal Impairment In Myeloma A Pathological Analysis of Renal Findings In 41 Autopsied Cases

Multi-Organ Involvement of Multiple Myeloma Cells In the Cases of Recent 10 Years: A Clinicopathologic Study of 81 Consecutively Autopsied Cases

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only